Navigation Links
Fresenius Sued Again in Cardiac Death Lawsuit
Date:2/28/2013

BOSTON, Feb. 28, 2013 /PRNewswire/ -- Nix Patterson and Roach, LLP and Feazell & Tighe LLP announce the filing of a wrongful death lawsuit against the manufacturer of GranuFlo®, Fresenius Medical Care North America.  The lawsuit was filed in Boston federal court on February 27, 2013, by Bettye Alexander , whose late husband Gary Alexander suffered a heart attack and died following hemodialysis treatment using GranuFlo®.  Mrs. Alexander alleges that Fresenius failed to warn that GranuFlo®, which has been used as part of a dialysate prescription at thousands of dialysis clinics over the last decade, puts patients at a substantially higher risk of cardiac arrest, stroke, and sudden cardiac death. 

Nix Patterson & Roach, LLP and Feazell & Tighe LLP currently represent more than 1300 people alleged to have suffered cardiac arrest, stroke, or sudden cardiac death following the use of GranuFlo® or a similar Fresenius dialysate product, NaturaLyte®

The lawsuit alleges that Fresenius was aware of the risk for years, long before Mr. Alexander underwent his hemodialysis treatment.  An internal memo written by Fresenius in November 2011 warned that the use of GranuFlo® was associated with a 6 to 8 fold greater increase of cardiopulmonary arrest and sudden cardiac death in the dialysis facility.  That internal memo, which covered only a single year and a third of Fresenius's clinics, identified 947 cardiac deaths.  Fresenius sent that internal memo to its own network of dialysis clinics.  But Fresenius sells GranuFlo® to thousands of other dialysis clinics as well.  It did not share this information with any of them until almost five months later.  The internal memo was leaked anonymously to the FDA in March, 2012, and a recall of GranuFlo® and a similar product, NaturaLyte®, was issued later that month.  For more information on the recall, please visit http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm

Mrs. Alexander, who is also represented by Kreindler & Kreindler LLP, seeks compensatory and punitive damages for the unnecessary and unfortunate death of her husband.

Plaintiffs with cases against Fresenius have filed with the Judicial Panel of Multidistrict Litigation (JPML), seeking to consolidate all GranuFlo® lawsuits in a single federal court in order to coordinate pretrial proceedings and efficiently manage the litigation.  Fresenius has joined in that request. 

If you suspect you or a loved one has been injured by GranuFlo® or NaturaLyte®, call Feazell & Tighe LLP toll-free at 877-508-0588, http://www.feazell-tighe.com or email Austin Tighe at austin@feazell-tighe.com .

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.


'/>"/>
SOURCE Feazell & Tighe LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PCMA: The Drugstore Lobby (Again) Looks to Avoid Fraud and Abuse Detection
2. Safe in Commons "The Unfinished Agenda: Addressing the Challenges" Crystalizes Call for Unified Protection Against Needlestick and Sharps Injuries
3. OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
4. Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
5. Labaton Sucharow Secures $473 Million Settlement In Case Against Schering-Plough Corporation
6. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
7. Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
8. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
9. Suture Express Files Antitrust Lawsuit Against Cardinal Health and Owens & Minor
10. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
11. Robbins Umeda LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Abiomed, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):